Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of Asia Pacific Market by Drug Class 38
3.1 Market Overview by Drug Class 38
3.2 Cephalosporin 40
3.3 Penicillin 42
3.4 Macrolides 43
3.5 Tetracycline 44
3.6 Quinolones 45
3.7 Sulfonamides 46
3.8 Aminoglycosides 47
3.9 Other Drug Classes 48

4 Segmentation of Asia Pacific Market by Action Mechanism 49
4.1 Market Overview by Action Mechanism 49
4.2 Cell Wall Synthesis Inhibitors 51
4.3 Mycolic Acid Inhibitors 52
4.4 RNA Synthesis Inhibitors 53
4.5 DNA Synthesis Inhibitors 54
4.6 Protein Synthesis Inhibitors 55
4.7 Other Mechanisms 56

5 Segmentation of Asia Pacific Market by Drug Origin 57
5.1 Market Overview by Drug Origin 57
5.2 Natural Antibiotics 59
5.3 Semi-synthetic Antibiotics 60
5.4 Synthetic Antibiotics 61

6 Segmentation of Asia Pacific Market by Activity Spectrum 62
6.1 Market Overview by Activity Spectrum 62
6.2 Broad-spectrum Antibiotics 64
6.3 Narrow-spectrum Antibiotics 65

7 Segmentation of Asia Pacific Market by Application 66
7.1 Market Overview by Application 66
7.2 Urinary Tract Infections (UTIS) 68
7.3 Dental Infections 69
7.3.1 Monotherapies for Dental Infections 70
7.3.2 Combined Therapies for Dental Infections 71
7.4 Respiratory Tract Infections (RTIS) 72
7.4.1 Upper Respiratory Tract Infections (URTI) 73
7.4.2 Lower Respiratory Tract Infections (LRTIs) 74
7.5 Other Applications 75

8 Segmentation of Asia Pacific Market by Drug Type 76
8.1 Market Overview by Drug Type 76
8.2 Brand Antibiotics 78
8.3 Generic Antibiotics 79

9 Asia-Pacific Market 2019-2030 by Country 80
9.1 Overview of Asia-Pacific Market 80
9.2 Japan 83
9.3 China 86
9.4 Australia 88
9.5 India 90
9.6 South Korea 92
9.7 Rest of APAC Region 94

10 Competitive Landscape 96
10.1 Overview of Key Vendors 96
10.2 New Product Launch, Partnership, Investment, and M&A 99
10.3 Company Profiles 100
Abbott Laboratories 100
Astellas Pharma 102
AstraZeneca Plc 103
Bayer AG 104
Bristol Myers Squibb Company 105
Cipla Inc. 106
Dr. Reddy’s Laboratories Ltd. 107
Eli Lilly and Company 108
F. Hoffmann-La Roche Ltd. 109
Gilead Sciences, Inc. 110
GlaxoSmithKline plc. 111
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 112
Mayne Pharma Group Ltd. 113
MELINTA THERAPEUTICS, INC. 114
Merck KGaA 115
Novartis AG 116
Pfizer Inc. 117
Sanofi 118
Sun Pharmaceutical Industries Ltd. 119

11 Investing in Asia Pacific Market: Risk Assessment and Management 120
11.1 Risk Evaluation of Asia Pacific Market 120
11.2 Critical Success Factors (CSFs) 123
Related Reports and Products 126



List of Figures


Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Oral Antibiotics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Oral Antibiotics Market 23
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 26
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 26
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Oral Antibiotics Market 27
Figure 11. Investment Opportunity Analysis 31
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Oral Antibiotics Market 34
Figure 13. Breakdown of Asia Pacific Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 39
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%) 39
Figure 15. Asia Pacific Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn 40
Figure 16. Asia Pacific Oral Antibiotics Market: Penicillin, 2019-2030, $ mn 42
Figure 17. Asia Pacific Oral Antibiotics Market: Macrolides, 2019-2030, $ mn 43
Figure 18. Asia Pacific Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn 44
Figure 19. Asia Pacific Oral Antibiotics Market: Quinolones, 2019-2030, $ mn 45
Figure 20. Asia Pacific Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn 46
Figure 21. Asia Pacific Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn 47
Figure 22. Asia Pacific Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn 48
Figure 23. Breakdown of Asia Pacific Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 50
Figure 24. Asia Pacific Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%) 50
Figure 25. Asia Pacific Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn 51
Figure 26. Asia Pacific Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn 52
Figure 27. Asia Pacific Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn 53
Figure 28. Asia Pacific Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn 54
Figure 29. Asia Pacific Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn 55
Figure 30. Asia Pacific Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn 56
Figure 31. Breakdown of Asia Pacific Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 58
Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%) 58
Figure 33. Asia Pacific Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn 59
Figure 34. Asia Pacific Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn 60
Figure 35. Asia Pacific Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn 61
Figure 36. Breakdown of Asia Pacific Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 63
Figure 37. Asia Pacific Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%) 63
Figure 38. Asia Pacific Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn 64
Figure 39. Asia Pacific Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn 65
Figure 40. Breakdown of Asia Pacific Oral Antibiotics Market by Application, 2019-2030, % of Revenue 67
Figure 41. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 67
Figure 42. Asia Pacific Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn 68
Figure 43. Asia Pacific Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn 69
Figure 44. Asia Pacific Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn 70
Figure 45. Asia Pacific Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn 71
Figure 46. Asia Pacific Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn 72
Figure 47. Asia Pacific Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn 73
Figure 48. Asia Pacific Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn 74
Figure 49. Asia Pacific Oral Antibiotics Market: Other Applications, 2019-2030, $ mn 75
Figure 50. Breakdown of Asia Pacific Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 76
Figure 51. Asia Pacific Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%) 77
Figure 52. Asia Pacific Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn 78
Figure 53. Asia Pacific Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn 79
Figure 54. Breakdown of APAC Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 81
Figure 55. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 82
Figure 56. Oral Antibiotics Market in Japan, 2019-2030, $ bn 84
Figure 57. Oral Antibiotics Market in China, 2019-2030, $ bn 86
Figure 58. Oral Antibiotics Market in Australia, 2019-2030, $ bn 88
Figure 59. Oral Antibiotics Market in India, 2019-2030, $ bn 90
Figure 60. Oral Antibiotics Market in South Korea, 2019-2030, $ bn 92
Figure 61. Oral Antibiotics Market in Rest of APAC, 2019-2030, $ bn 94
Figure 62. Growth Stage of Asia Pacific Oral Antibiotics Industry over the Forecast Period 96


List of Tables


Table 1. Snapshot of Asia Pacific Oral Antibiotics Market, 2019-2030 18
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Oral Antibiotics Market 30
Table 3. Asia Pacific Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 38
Table 4. Asia Pacific Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, $ mn 41
Table 5. Asia Pacific Oral Antibiotics Market by Action Mechanism, 2019-2030, $ mn 49
Table 6. Asia Pacific Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 57
Table 7. Asia Pacific Oral Antibiotics Market by Activity Spectrum, 2019-2030, $ mn 62
Table 8. Asia Pacific Oral Antibiotics Market by Application, 2019-2030, $ mn 66
Table 9. Asia Pacific Oral Antibiotics Market: Dental Infections by Type, 2019-2030, $ mn 69
Table 10. Asia Pacific Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, $ mn 72
Table 11. Asia Pacific Oral Antibiotics Market by Drug Type, 2019-2030, $ bn 76
Table 12. APAC Oral Antibiotics Market by Country, 2019-2030, $ bn 81
Table 13. Japan Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 85
Table 14. Japan Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 85
Table 15. Japan Oral Antibiotics Market by Application, 2019-2030, $ mn 85
Table 16. China Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 87
Table 17. China Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 87
Table 18. China Oral Antibiotics Market by Application, 2019-2030, $ mn 87
Table 19. Australia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 89
Table 20. Australia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 89
Table 21. Australia Oral Antibiotics Market by Application, 2019-2030, $ mn 89
Table 22. India Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 91
Table 23. India Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 91
Table 24. India Oral Antibiotics Market by Application, 2019-2030, $ mn 91
Table 25. South Korea Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 93
Table 26. South Korea Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 93
Table 27. South Korea Oral Antibiotics Market by Application, 2019-2030, $ mn 93
Table 28. Oral Antibiotics Market in Rest of APAC by Country, 2019-2030, $ bn 95
Table 29. Abbott Laboratories: Company Snapshot 100
Table 30. Abbott Laboratories: Business Segmentation 100
Table 31. Abbott Laboratories: Product Portfolio 101
Table 32. Abbott Laboratories: Revenue, 2016-2018, $ mn 101
Table 33. Abbott Laboratories: Recent Developments 101
Table 34. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 121
Table 35. Critical Success Factors and Key Takeaways 124